INTRODUCTION
Eukaryotic DNA is packaged into highly dynamic chromatin, the basic unit of which is the nucleosome. This consists of a central "hub", comprising two of each of the core histone proteins H2A, H2B, H3 and H4, around which are wrapped 146 bp of DNA . The highly conserved histone proteins are subject to several post-translational modifications, including acetylation, phosphorylation, methylation and sumoylation.
Extensive studies have forged a link between the acetylation state of chromatin and its transcriptional status. Dynamic acetylation and deacetylation of lysine residues within the N-terminal tails of core histones seem to be necessary for a series of crucial nuclear events such as silencing, replication and correct DNA repair.
Initial research into the relevance of histone acetylation aimed at identifying and characterizing the enzymes involved, that is the histone acetyltransferases and their antagonists, the histone deacetylases (HDACs). Class I HDACs, which include HDAC1, HDAC2, HDAC3, HDAC8 and HDAC11, have been implicated in the regulation of cell cycle progression, differentiation and development (1) , and a series of studies have revealed a potential role for HDACs in carcinogenesis (reviewed in (2) ).
The prototypical histone deacetylase HDAC1, a homologue of the S. cerevisiae transcriptional modulator Rpd3 (3), was first identified using a trapoxin affinity matrix (4) . An important aspect of HDAC1 function is its target specificity, determined predominantly by the precise composition of HDAC1-containing complexes and the nature of HDAC1 associated proteins. Apart from the well characterized SIN3 and NuRD complexes ((1,5) and references therein), an additional HDAC1-containing complex, named CoREST, has been isolated from human cells (6, 7) . HDAC2, the second member of the class I deacetylases, is commonly found within the same complexes as HDAC1 (1, (5) (6) (7) .
The third class I deacetylase HDAC3 is generally found to be associated with the corepressors SMRT and N-CoR, as well as with the class II deacetylase enzymes HDAC4 and HDAC5 (reviewed in (8) ). As yet, little is known about the function of the two other members of the class I histone deacetylase family, the recently described HDAC8 (9) (10) (11) and HDAC11 (12) . Class II enzymes, comprising HDACs 4-7 and HDAC9-10, are generally linked to the regulation of differentiation-related genes, and, in contrast to the strictly nuclear class I deacetylases HDAC1 and HDAC2 are found in both the nucleus and cytoplasm of cells (13) . Class III deacetylases have been implicated in gene silencing and control of aging (14, 15) .
A large number of transcription factors regulate gene expression through the recruitment of histone deacetylase complexes. Nuclear hormone receptors are wellcharacterized examples of HDAC-recruiting proteins. Initially, the retinoic acid receptors and thyroid receptors were shown to interact indirectly with HDACs, through their interaction with N-CoR and SMRT in the absence of ligand (16, 17) .
Recruitment of HDAC2 through N-CoR and SMRT was also described for steroid receptors in the presence of partial antihormones (18) . Similarly, HDACs associate both in vitro and in vivo with different transcription cofactors that bind nuclear receptors in the presence of agonists (19) (20) (21) . More recently, a direct association between HDACs and nuclear receptors was reported (22) , thus increasing the complexity of the interaction between these two types of partners.
HDAC1 is certainly the best-studied mammalian histone deacetylase. The enzyme is not only essential for mouse development, but also for normal proliferation of mouse embryos and embryonic stem cells (23) . HDAC1 expression has to be tightly regulated since both overexpression and loss of HDAC1 result in severe disturbance of proliferation and cell cycle progression (23, 24) . Transcription of the murine HDAC1 gene is induced by cooperative phosphorylation and acetylation signals, allowing both growth factor-dependent activation and feedback regulation (25, 26) . In addition, post-translational modifications seem to be important for the biological function of the enzyme and the regulation of its activity by other factors (27) (28) (29) .
HDAC1 has been shown to form homodimers and to associate with HDAC2 (30, 31) .
This has already led us to propose dimerization as a pivotal event for HDAC1 enzymatic activity (30) . Apart from this, specific recruiting factors are required to confer high target specificity upon HDAC1. To this aim, we employed the yeast twohybrid system to isolate hitherto unknown interaction partners of HDAC1. One of the candidate proteins isolated was the repressor of estrogen receptor activity (REA) (32) .
By co-immunoprecipitation experiments and glutathione-S-transferase (GST) pulldown assays, we established the interaction between REA and both HDAC1 and HDAC5. Moreover, we demonstrated that REA specifically interacts not only with estrogen receptor, but also with the orphan nuclear receptors chicken ovalbumin upstream binding-transcription factor (COUP-TF) I and II. Our data identify REA as novel HDAC-interacting protein that modulates the activity of a defined subset of nuclear hormone receptors. Northern blot analysis. mRNA expression was analyzed using the Northern blot sandwich method as described previously (35) .
Antibodies. To raise a specific antibody directed against mouse REA, the 6xHis-tagged fragment (aa 89 to 299) expressed in E. coli BL21 DE3 pLysS was used to immunize rabbits by standard methods. Antibodies were affinity-purified by overnight incubation on nitrocellulose strips loaded with recombinant His-REA. After washing with 10 mM Tris-HCl pH 8.0 and 10 mM Tris-HCl pH 8.0, 0.5 M NaCl, bound antibodies were eluted by sequential incubation with 100 mM glycine pH 2.5 and 100 mM triethylamine pH 10.0. Eluates were neutralized by addition of 1 M Tris-HCl pH 8.0 and tested for specificity by Western blot analysis. The REA antibody described above, as well the HDAC1 monoclonal antibody 10E2 and the RbAp48 monoclonal antibody 13D10 are commercially available at Upstate USA. The estrogen receptor alpha antibody H-184, the Gal4 DNA-BD monoclonal antibody and the MTA1 antibody C-17 were purchased from Santa Cruz. Other antibodies used in this study were the HA-specific monoclonal antibodies 12CA5 and 16B12 and the GFP monoclonal antibody from Clontech.
Glutathione-S-transferase pull-down assays. GST-fusion proteins were expressed in E. coli BL21 DE3 pLysS. GST-fusion proteins with HDAC1, HDAC2 and HDAC3 have been described previously (30) . GST-SRC-1 and expression vectors for RXRα and TRα were obtained from M.G. Parker. Large-scale preparation, purification of the recombinant proteins and binding to the glutathione beads were performed as previously described (36) . Beads coated with GST-fusion proteins were incubated with in vitro translated, 35 was assessed by measuring ß-galactosidase levels in an 80 µl aliquot of the cell lysate using an o-nitrophenyl-beta-D-galactopyranoside-based liquid assay. Additionally, an aliquot of each extract was analyzed on Western blots to evaluate the levels of coexpressed proteins.
RESULTS

REA interacts with HDAC1 in the yeast two-hybrid system
The class I enzyme HDAC1 is present within three large multi-protein complexes, referred to as the SIN3, NuRD (reviewed in (5)) and CoREST complexes (7). 
Expression and intracellular localization of REA
We first looked at the expression pattern of REA in a variety of tissues and cell lines. To analyze REA protein expression, we raised a REA-specific polyclonal antiserum using bacterially expressed, purified 6xHis-tagged REA protein (aa 89-299).
Specificity of the REA antiserum was confirmed by Western blot analysis and further enhanced by affinity purification against the antigen (data not shown). This affinitypurified antibody detected a single band corresponding to a 37 kDa protein in Western blots of whole cell protein extracts from a variety of established human and mouse cell lines (Fig. 1D) . Among those tested were the human osteosarcoma cell line U2OS and the human mammary carcinoma cell line MCF-7. Mouse cell lines analyzed for REA expression were the IL2-dependent T cell line B6.1 and primary erythroblasts, as well as embryonic stem cells derived from HDAC1 wildtype and homozygous mutant mice. In addition, a signal at 37 kDa was also detected in whole cell protein extracts from rat embryonic fibroblasts, indicating reactivity of the antibody for human, mouse and rat species. HDAC1 protein was present in all cell lines tested, with the exception of the HDAC1 -/-ES cells.
To establish further the connection between REA and the nuclear enzyme HDAC1, In a separate approach, we analyzed the intracellular localization of REA by Western blot analysis of biochemically fractionated cell extracts. Logarithmically growing MCF-7 cells were harvested and used to prepare cytoplasmic versus nuclear extracts (as described in the Experimental Procedures). Sequential probing with antibodies specific for REA and HDAC1 confirmed that a significant portion of REA was present in the nuclear fraction, coincident with the localization of HDAC1 (Fig. 2B ).
Probing with a tubulin-specific antibody indicated only minimal contamination of nuclear fractions with cytoplasmic proteins.
In vivo association of REA with HDAC1
To demonstrate the in vivo interaction between REA and HDAC1, we decided to precipitate endogenous REA and analyze co-precipitated proteins for the presence of HDAC1. Whole cell protein extracts prepared from logarithmically growing MCF-7 cells were used for immunoprecipitation with REA antibody or, as a negative control, with the corresponding pre-immune serum. Precipitated proteins were analyzed for associated HDAC1 by Western blotting (Fig. 3A) . Duplicate immunoprecipitations were used for HDAC activity assays (Fig. 3B ).
As illustrated in Fig. 3A , REA was precipitated by the REA specific antibody, but not by the pre-immune serum. Furthermore, HDAC1 was associated with immunoprecipitated REA, as determined by probing of the Western blot with HDAC1
antibody. Consistent with this finding, HDAC assays using immunoprecipitated fractions showed that considerable levels of HDAC activity were associated with REA ( Fig. 3B ). These were comparable to activities measured in RbAp48 Conversely, to analyze REA association with immunoprecipitated HDAC1, whole cell protein extracts were subjected to immunoprecipitation with the HDAC1 monoclonal antibody 10E2 and, as control, with an unrelated monoclonal antibody.
Precipitated proteins were then examined by Western blot analysis. As shown in Fig.   3C , REA specifically co-immunoprecipitated with the HDAC1 protein, confirming an in vivo interaction between REA and HDAC1.
In vitro interaction between HDAC1 and REA
To define the HDAC1-REA interaction domains within both proteins, we performed with the fact that, in the two-hybrid screen, REA was identified using the C-terminal half of the HDAC1 protein as bait. Further subdivision of the C-terminus into two parts (delB and delC) resulted in polypeptides which retained their binding capacity for REA, suggesting the existence of two distinct REA binding domains (Fig. 4B) .
To define the HDAC binding region within REA, the REA polypeptide was subdivided into a series of complementary fragments and fused to GST (represented schematically in Fig. 4A ). Pull-down experiments were performed with these constructs or full-length REA fused to GST using radiolabeled full-length HDAC1.
As can be seen in Fig. 4C , GST-REA interacted with HDAC1, while the unrelated control protein LR8 showed no interaction. GST-REAdel9 (aa 185-299) was sufficient for interaction with HDAC1. However, in addition to this carboxy-terminal association region, REA bound HDAC1 via a second domain located within the N- Interestingly, members of the HDAC class II family, such as HDAC5, also bound to REA in GST pull-down assays (Fig. 4E) . When compared to HDAC1, HDAC5
showed in part different specificity with respect to the interaction domains within the 
REA acts as a transcriptional repressor
Although REA was initially described as a repressor of estrogen receptor activity showing an association between REA and histone deacetylases indicated that REA could additionally act as a repressor on its own. We therefore decided to assess the possible repressive function of this protein using mammalian in vivo reporter gene assays. We cloned full-length REA as a C-terminal fusion to the Gal4 DNA binding domain (DBD). This construct was transiently transfected into U2OS cells, together with a plasmid carrying a luciferase reporter cassette under the control of a SV40 TK promoter preceded by four Gal4 binding sites (39) .
Luciferase levels upon co-transfection of the Gal4 DBD alone were arbitrarily set to 100%. Transfection of the Gal4DBD-REA expressing construct led to a reduction of luciferase activity to 40% of the control value (Fig. 5A, gray bars) . Based upon the interaction of REA with HDACs, we asked the question whether the observed repression could be alleviated by treatment with an HDAC inhibitor. Indeed, REAmediated repression of the reporter cassette was nearly completely abolished by treatment with the deacetylase inhibitor trichostatin A (TSA) (Fig. 5A , black bars), a known specific inhibitor of histone deacetylases. Western blot analysis of Gal4DBD-REA expression levels confirmed that the reduced repressor function of REA in response to TSA treatment was not due to decreased expression of the Gal4DBD-REA fusion protein (Fig. 5B) . A fusion construct between Gal4 DBD and GRG4 (39), a member of the mammalian Groucho family known to be independent of deacetylases for its transcriptional repression, was used as control (Fig. 5A) . In contrast to REA, GRG4 mediated repression was not affected by treatment with TSA.
A subset of nuclear hormone receptors interacts with REA
Next, we examined the specificity of the association between REA and ERα by GST pull-down assays. Consistent with the initial reports characterizing REA as a repressor of estrogen receptor activity (32, 41, 42) , GST-REA precipitated radiolabeled ERα in a ligand-independent manner, but did not interact with retinoic acid receptor RXRα or thyroid hormone receptor TRα (Fig. 6A) . In contrast, the co-activator SRC-1 associated with all three nuclear receptors in the presence of the respective ligand (Fig. 6A) .
In addition, we tested the orphan nuclear hormone receptors COUP-TF I and II for interaction with REA. These nuclear receptors have been implicated in the shut-off of MHC I transcription (43) and play important roles in embryonic development (reviewed in (44)). Interestingly, GST-REA had a very high affinity for COUP-TFI and COUP-TFII (Fig. 6B) . While ER-α interacted with both the N-terminal and the C-terminal portion of REA, COUP-TFII preferentially associated with the N-terminal portion of REA (Fig. 6C) . In GST pull-down assays, full length COUP-TFII and a mutant lacking the N-terminus (COUP-TFII(56-414)) efficiently associate with in vitro translated REA (Fig. 6D) . In contrast, the N-terminal part of COUP-TF did not interact with REA, suggesting that the C-terminal part of the receptor is sufficient for association with the REA protein.
Next, we asked whether REA associates in vivo with nuclear hormone receptors. In parallel, we tested the ERα immunoprecipitates for HDAC activity and found that ERα was associated with significant deacetylase activity (Fig. 7B ).
To examine a potential in vivo association of the COUP-TF orphan receptor with REA, we expressed HA-REA together with GFP-COUP-TFI or GFP in HeLa cells.
As shown in Fig. 7C , immunoprecipitated REA protein was associated with GFP-COUP-TFI, but not with GFP alone. Taken together, these data show a specific in vivo interaction of REA with ERα and COUP-TF, suggesting that these nuclear receptors could be specifically targeted by the REA-HDAC complexes. The C-terminal part of HDAC1 contains at least two important motifs: The IACEE motif required for interaction with the tumor suppressor Rb (52, 53) and the functional nuclear localization signal KKAKRVK (30) . In addition, the C-terminal part of HDAC1 is a target for modification by sumoylation and phosphorylation (27, 28) .
REA acts as a transcriptional co-repressor of the orphan receptor COUP-TFI
Sumoylation of lysine residues seems to be required for the transcriptional repressor function of HDAC1, but not for the binding of the adapter protein Sin3A (28) . The data presented in this study indicate that HDAC1 interacts with the co-repressor REA through its C-terminal domain, suggesting that the HDAC1 protein contains specific interaction surfaces for different adapter proteins.
REA most probably interacts directly with HDAC1 via two independent domains located in the N-terminus (aa 1-117) and the C-terminus (aa 185-299), respectively.
The fact that binding activity of the full-length protein is higher than that of the individual domains suggests a cooperativity of these two domains. Interestingly, although isolated in this study as interacting with HDAC1, REA can form stable interactions with other members of the histone deacetylase family, intriguingly even with class II deacetylases, e.g. HDAC5. Notably, the interaction with HDAC5
requires only the N-terminal part of REA. This N-terminal domain, that is also involved in the interaction with HDAC1, contains RD1, one of the two domains previously shown to possess transcriptional repression activity (32) . Consistent with these findings, REA immunoprecipitates show remarkably robust deacetylase activity in murine and human cell lines. Taken together, these data indicate that the REA protein has to be considered as a co-repressor that can recruit several members of the HDAC family.
The REA protein was originally identified as BAP37, a factor characterized as a Bcell receptor associated protein (34, 54) . As shown in this study, REA mRNA and protein are expressed in a large variety of tissues and cell lines, arguing against a Bcell restricted function. A significant portion of REA molecules shows nuclear localization and is found in association with the nuclear deacetylase HDAC1. U2OS cells were transiently transfected with the Gal4 reporter plasmid and the Gal4DBD-REA plasmid and left untreated or treated with TSA as described above.
REA as transcriptional co-repressor of nuclear hormone receptors
Protein extracts were prepared and analyzed for expression of Gal4DBD-REA and as control for endogenous REA. 
